Profound Medical Corp Stock Toronto S.E.
Equities
PRN
CA74319B1067
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- CAD | - |
|
Jul. 16 | Stifel Upgrades Profound Medical to Buy From Hold, Raises Price Target to $12 From $9 | MT |
Jul. 11 | Profound Medical Says U.S. Medicare Rules Proposed for TULSA Procedure | MT |
Sales 2024 * | 15.47M 11.3M | Sales 2025 * | 38.71M 28.27M | Capitalization | 326M 238M |
---|---|---|---|---|---|
Net income 2024 * | -40M -29.22M | Net income 2025 * | -30M -21.91M | EV / Sales 2024 * | 21.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 8.42 x |
P/E ratio 2024 * |
-8.31
x | P/E ratio 2025 * |
-9.96
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.31% |
Latest transcript on Profound Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 69 | 15-06-03 |
Rashed Dewan
DFI | Director of Finance/CFO | 56 | 15-06-30 |
Mathieu Burtnyk
COO | Chief Operating Officer | 42 | 11-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Rosenthal
BRD | Director/Board Member | 77 | 18-06-13 |
Director/Board Member | 67 | 18-06-13 | |
Cynthia Lavoie
BRD | Director/Board Member | - | 21-03-02 |
1st Jan change | Capi. | |
---|---|---|
+4.46% | 212B | |
+9.04% | 187B | |
+27.99% | 155B | |
+34.03% | 115B | |
+2.21% | 65.5B | |
+14.40% | 52.87B | |
-6.47% | 45.25B | |
-3.39% | 39.7B | |
+6.65% | 37.72B |
- Stock Market
- Equities
- PRN Stock
- PRN Stock